Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other financing activities (2018 - 2022)

Historic Other financing activities for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Q4 2022 value amounting to $1000.0.

  • Avadel Pharmaceuticals' Other financing activities changed N/A to $1000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2023, which is 930.47% down from last year.
  • According to the latest figures from Q4 2022, Avadel Pharmaceuticals' Other financing activities is $1000.0.
  • Avadel Pharmaceuticals' 5-year Other financing activities high stood at $2.9 million for Q4 2018, and its period low was -$129000.0 during Q2 2019.
  • Moreover, its 3-year median value for Other financing activities was -$36000.0 (2019), whereas its average is $307444.4.
  • Data for Avadel Pharmaceuticals' Other financing activities shows a peak YoY increase of 9574.47% (in 2019) and a maximum YoY decrease of 21463.41% (in 2019) over the last 5 years.
  • Avadel Pharmaceuticals' Other financing activities (Quarter) stood at $2.9 million in 2018, then crashed by 101.22% to -$36000.0 in 2019, then surged by 102.78% to $1000.0 in 2022.
  • Its last three reported values are $1000.0 in Q4 2022, -$36000.0 for Q4 2019, and -$72000.0 during Q3 2019.